| Metric | Value (₹ Cr) | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue | 857.65 | 5.2% | 18.5% |
| Total Income | 862.52 | 5.1% | 18.6% |
| Expenditure | 604.16 | 2.6% | 10.4% |
| PBT | 258.36 | 11.5% | 43.5% |
| Net Profit | 205.97 | 12.3% | 39.4% |
| OPM | 35.01% | 0.46pp | 3.77pp |
| NPM | 23.88% | 1.54pp | 3.56pp |
| EPS | 12.31 | 12.3% | 38.6% |
IKS Health FY26 Revenue Up 20%, PAT Surges 48%
13 May 2026 · 13 May, 8:11 pm
Summary
Inventurus Knowledge Solutions (IKS Health) announced strong financial performance for the fiscal year and quarter ended March 31, 2026. The company reported a 20% year-on-year revenue growth to ₹31,938 million for FY26, alongside an impressive 48% surge in Profit After Tax (PAT) to ₹7,216 million. For Q4 FY26, revenue increased by 18.5% year-on-year to ₹8,577 million, with PAT rising 39.4% year-on-year and 12% quarter-on-quarter. CEO Sachin K. Gupta highlighted the scalability of their care enablement platform and the 'AI + Human' model as key drivers, affirming the company's financial strength for accelerated AI-driven momentum in FY27. CFO Nithya Balasubramanian underscored exceptional operational discipline, contributing to 38% YoY EBITDA growth and significant margin expansion, positioning IKS Health for continued technology investment and sustainable shareholder value.
Key Highlights
- 1
Inventurus Knowledge Solutions (IKS Health) reported robust FY26 financial results with revenue growing by 20% year-on-year to ₹31,938 million.
- 2
Profit After Tax (PAT) for the full fiscal year 2026 surged significantly by 48% year-on-year to ₹7,216 million.
- 3
EBITDA for FY26 reached ₹10,913 million, representing a substantial 38% increase year-on-year.
- 4
In Q4 FY26, the company recorded revenue of ₹8,577 million, an increase of 18.5% year-on-year.
- 5
Q4 FY26 PAT demonstrated strong growth, rising by 39.4% year-on-year to ₹2,060 million and 12% quarter-on-quarter.
- 6
IKS Health expanded its AI portfolio by acquiring ThinkDTM and launched next-gen Epic-integrated solutions, including an Autonomous RCM Coding Engine and MyCareHub™.
- 7
The company secured new strategic AI partnerships and expanded its market reach through client wins with Holyoke Medical Center and Mission Community Hospital.
Management Comments
Sachin K. Gupta
Our performance this fiscal year underscores the deep value we bring to clinician enterprises as they navigate an increasingly complex US healthcare landscape. Ending the year with a strong 20% YoY revenue growth in FY 2026 is a testament to the scalability of our care enablement platform. Our 'AI + Human' model is now the industry standard for sustainable growth, as proven by our expanding partnerships with top-tier health systems. By deploying autonomous engines and agentic AI like MyCareHub™, we are providing the clinical and financial intelligence needed to transform care delivery. We enter FY27 with the financial strength to accelerate this AI-driven momentum.
Nithya Balasubramanian
Our fiscal year concluded with exceptional operational discipline, reflected in our 38% YoY EBITDA growth and significant margin expansion. The 48% rise in PAT for the year demonstrates our ability to scale efficiently and deliver profitable growth through a resilient business model which leverages the latest technology and global delivery. With a strong balance sheet and robust cash flow generation, we are well-positioned to continue investing in our technology platform to drive long-term, sustainable value for our shareholders.
Informational and educational content only. Not investment advice.